Skip to content
Portage Biotech
Portage BiotechPortage Biotech
  • about us
    • overview
    • leadership
  • our pipeline
    • iNKT platform
    • adenosine platform
    • other programs in development
  • investors
    • overview
    • stock information
    • news releases
    • investor calendar
    • presentations & publications
    • sec filings
    • financial & regulatory reports
    • corporate governance
    • investor faqs
  • join our team
  • contact
  • about us
    • overview
    • leadership
  • our pipeline
    • iNKT platform
    • adenosine platform
    • other programs in development
  • investors
    • overview
    • stock information
    • news releases
    • investor calendar
    • presentations & publications
    • sec filings
    • financial & regulatory reports
    • corporate governance
    • investor faqs
  • join our team
  • contact

Daily Archives: July 7, 2022

BioSpace: Portage Adds Four Adenosine Candidates to Pipeline in Tarus Buyout

Media CoverageBy Gwen SchankerJuly 7, 2022
...

Fierce Biotech: Portage raids fellow biotech Tarus for adenosine receptor treasures

Media CoverageBy Gwen SchankerJuly 7, 2022
...

ENDPOINTS: Low-profile biotech led by Bristol Myers vets grabs a suite of adenosine receptor antagonists via tiny buyout

Media CoverageBy Gwen SchankerJuly 7, 2022
...
Copyright © All rights reserved Portage Biotech, Inc

terms of use   privacy policy   disclaimer

Go to Top